Phase III Trial

Biotech News

Ris-Rez Hits Phase III Survival Endpoint in Small-Cell Lung Cancer
Biotech Blogs

World Clinical Trials Day 2026 Looks at the Science, Setbacks and Systems Behind New Medicines

Chronic Inflammatory Dermatoses: Designing Trials for Late-Stage Success

May 12, 2026
Biotech News

Five-Year Follow-Up Data Released for mRNA Cancer Vaccine in Melanoma
Clinical Trial News

Bepirovirsen Shows Promise in Phase III for Chronic Hepatitis B
Clinical Trial News

Aleniglipron Moves Toward Phase III as Structure Therapeutics Advances Oral GLP-1 Obesity Program
Biotech News

Oral Semaglutide Fails to Slow Alzheimer’s Decline in Phase III
Clinical Trial News

Asundexian Meets Primary Endpoints in Bayer’s Phase III Secondary Stroke Prevention Trial
Clinical Trial News

Merck’s Enlicitide Decanoate Shows LDL-C Reduction in Phase III
Clinical Trial News

Obefazimod Shows Remission Improvements in New Phase III Ulcerative Colitis Results
Biotech News

GSK Ends Cobolimab NSCLC Program After Mid-Stage Trial Results
Biotech News

AstraZeneca’s Gefurulimab Shows Significant Functional Gains for gMG Patients in Phase III
Clinical Trial News

Obefazimod Phase III Success Pushes Abivax Stock to Record Highs
Biotech News

J&J’s Icotrokinra Shows Clear Skin Outcomes in Phase III
Biotech News

Novo Nordisk’s Amycretin Moves to Phase III: What Sets This Obesity Drug Apart?
Biotech News

Eneboparatide Advances in Hypoparathyroidism Trial: Key Phase III Update